Thomas McGauley
Net worth: 94 960 $ as of 2026-05-30
Net worth: 94 960 $ as of 2026-05-30
Thomas A. McGauley is currently a Member at Danforth Advisors LLC since 2021 and Chief Accounting Officer at Tenax Therapeutics, Inc. starting in 2024.
Formerly, Mr. McGauley was Chief Financial Officer & Accounting Director at Galectin Therapeutics, Inc. in 2012.
Education includes undergraduate studies at Stonehill College, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-07 | 8,000 ( 0.03% ) | 94 960 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2024-12-02 |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | 2021-06-30 |
| Companies | Position | End |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Director of Finance/CFO | 2013-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
Stonehill College, Inc.
Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions